An observational study in Myocardial Infarction, sponsored by Stiftung Institut fuer Herzinfarktforschung. Completed at 3 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-14.
Sponsored by Stiftung Institut fuer Herzinfarktforschung · Observational
The Myocardial Infarction Register Saarland (MIR-SL), is intended to collect data about the treatment of patients suffering from ST-elevation myocardial infarction (STEMI). It aims to provide current data on the implementation of guidelines for both, the interventional and adjuvant drug therapy of STEMI in daily clinical practice in the Saarland.
The Myocardial Infarction Register Saarland (MIR-SL), is intended to collect data about the treatment of patients suffering from ST-elevation myocardial infarction (STEMI). It aims to provide current data on the implementation of guidelines for both, the interventional and adjuvant drug therapy of STEMI in daily clinical practice in the Saarland.
In order to obtain representative data for the Saarland, preferably all consecutive patients should be documented comprehensively in the University Hospital of the Saarland, the non-university hospitals with cardiac catheterization laboratory as well as in hospitals without cardiac catheterization laboratory .
MIR-SL is attended by all 22 hospitals in Saarland, that treat patients with acute STEMI. A follow-up will be carried out after three months, 12 months and five years.
2,779 studies on the registry are indexed under Myocardial Infarction; 417 are open to participants now.
This study's enrollment of 455 is close to the median of 500 across 999 observational studies indexed under Myocardial Infarction.
Browse Myocardial Infarction studies →Stiftung Institut fuer Herzinfarktforschung is the lead sponsor of 26 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients admitted to a hospital in the Saarland region with ST elevation myocardial infarction, in the last 24 hours.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Rate of reperfusion therapies
Describe hospital daily routine in Germany
Time frame: 24 hours
Time before reperfusion therapy
pre-hospital time, intrahospital time, transfer time
Time frame: 24 hours
In-hospital mortality
Describe mortality before discharge
Time frame: 24 hours
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2016 to primary completion in Jul 2018, 21 months.
Of 377 non-industry observational studies under Myocardial Infarction, half reached primary completion within 49 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 132. This study's 21 months is below that.
Counting every sponsor, half of 418 studies reached it within 41 months; a quarter within 18 and three quarters within 113.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stiftung Institut fuer Herzinfarktforschung